Cargando…

Prognostic value of soluble suppression of tumorigenesis-2 (sST2) for cardiovascular events in coronary artery disease patients with and without diabetes mellitus

BACKGROUND: Soluble suppression of tumorigenesis-2 (sST2) is implicated in myocardial overload and has long been recognized as an inflammatory marker related to heart failure and acute coronary syndrome, but data on the prognostic value of sST2 in patients with coronary artery disease (CAD) remain l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Man, Duan, Lei, Cai, Yulun, Hao, Benchuan, Chen, Jianqiao, Li, Huiying, Liu, Hongbin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896409/ https://www.ncbi.nlm.nih.gov/pubmed/33608010 http://dx.doi.org/10.1186/s12933-021-01244-3

Ejemplares similares

Effects of liraglutide vs. lifestyle changes on soluble suppression of tumorigenesis-2 (sST2) and galectin-3 in obese subjects with prediabetes or type 2 diabetes after comparable weight loss
por: Simeone, Paola, et al.
Publicado: (2022)

Impact of the CYP2D6 Genotype on Metoprolol Tolerance and Adverse Events in Elderly Chinese Patients With Cardiovascular Diseases
por: Chen, Jianqiao, et al.
Publicado: (2022)

Association between allostatic load and adverse outcomes among older patients with heart failure with preserved ejection fraction
por: Hao, Benchuan, et al.
Publicado: (2023)

Waist to height ratio is associated with an increased risk of mortality in Chinese patients with heart failure with preserved ejection fraction
por: Chen, Jianqiao, et al.
Publicado: (2021)

Association of Soluble Suppression of Tumorigenesis 2 (sST2) With Platelet Activation, Monocyte Tissue Factor and Ischemic Outcomes Following Angioplasty and Stenting
por: Stojkovic, Stefan, et al.
Publicado: (2020)

Evaluation of interleukin-33 & sST2 levels in type-2 diabetic mellitus patients with or without metabolic syndrome
por: Singh, Himadri, et al.
Publicado: (2023)

A combination of NLR and sST2 is associated with adverse cardiovascular events in patients with myocardial injury induced by moderate to severe acute carbon monoxide poisoning
por: Liu, Qian, et al.
Publicado: (2021)

A meta-analysis of soluble suppression of tumorigenicity 2 (sST2) and clinical outcomes in pulmonary hypertension
por: Luk, King Sum, et al.
Publicado: (2017)

Prognostic Value of sST2 in Heart Failure
por: Sciatti, Edoardo, et al.
Publicado: (2023)

Reference interval and the role of soluble suppression of tumorigenicity 2 (sST2) in subclinical cardiac dysfunction at health checkups
por: Nah, Eun‐Hee, et al.
Publicado: (2020)

Differential and Predictive Value of Galectin-3 and Soluble Suppression of Tumorigenicity-2 (sST2) in Heart Failure with Preserved Ejection Fraction
por: Cui, Yameng, et al.
Publicado: (2018)

Value of increased soluble suppressor tumorigenicity biomarker 2 (sST2) on admission as an indicator of severity in patients with COVID-19
por: Arnaldos-Carrillo, María, et al.
Publicado: (2023)

The IL-33/sST2 Axis in Thromboangiitis Obliterans
por: Sharebiani, Hiva, et al.
Publicado: (2020)

Sex and age differences in sST2 in cardiovascular disease
por: Beetler, Danielle J., et al.
Publicado: (2023)

sST2 and Heart Failure—Clinical Utility and Prognosis
por: Dudek, Magdalena, et al.
Publicado: (2023)

Cardiac Biomarkers in the Emergency Department: The Role of Soluble ST2 (sST2) in Acute Heart Failure and Acute Coronary Syndrome—There is Meat on the Bone
por: Aleksova, Aneta, et al.
Publicado: (2019)

The Association of Serum IL-33 and sST2 with Breast Cancer
por: Yang, Zhi-Ping, et al.
Publicado: (2015)

Soluble IL-33 receptor sST2 inhibits colorectal cancer malignant growth by modifying the tumour microenvironment
por: Akimoto, Miho, et al.
Publicado: (2016)

Serum sST2 levels predict severe exacerbation of asthma
por: Watanabe, Masato, et al.
Publicado: (2018)

Soluble suppression of tumorigenicity 2 (sST2) for predicting disease severity or mortality outcomes in cardiovascular diseases: A systematic review and meta-analysis
por: Ip, Christina, et al.
Publicado: (2021)

Could sST2 Predict Contrast-Induced Nephropathy in ST-Segment Elevation Myocardial Infarction?
por: Avcı, Ahmet, et al.
Publicado: (2020)

sST2 association with atrial fibrillation development in patients with acute myocardial infarction with ST elevation
por: Rodionova, I, et al.
Publicado: (2023)

Soluble ST2 in the prediction of heart failure and death in patients with atrial fibrillation
por: Krittayaphong, Rungroj, et al.
Publicado: (2022)

Alteration of the IL-33-sST2 pathway in hypertensive patients and a mouse model
por: Yin, Xiaoyun, et al.
Publicado: (2019)

A Review of Novel Cardiac Biomarkers in Acute or Chronic Cardiovascular Diseases: The Role of Soluble ST2 (sST2), Lipoprotein-Associated Phospholipase A2 (Lp-PLA2), Myeloperoxidase (MPO), and Procalcitonin (PCT)
por: Li, Junpei, et al.
Publicado: (2021)

Comparison of longitudinal change in sST2 vs BNP to predict major adverse cardiovascular events in asymptomatic patients in the community
por: Watson, Chris J., et al.
Publicado: (2020)

Increased levels of sST2 in patients with mitral annulus disjunction and ventricular arrhythmias
por: Scheirlynck, Esther, et al.
Publicado: (2019)

Non-cardiac Conditions Which Can Elevate The Serum Levels of sST2
por: Patil, T.R., et al.
Publicado: (2019)

Short-Term Prognosis Value of sST2 for an Unfavorable Outcome in Hypertensive Patients
por: Farcaş, Anca Daniela, et al.
Publicado: (2020)

2-h postchallenge plasma glucose predicts cardiovascular events in patients with myocardial infarction without known diabetes mellitus
por: Henareh, Loghman, et al.
Publicado: (2012)

Circulating angiopoietin-2 and soluble Tie-2 in type 2 diabetes mellitus: a cross-sectional study
por: Rasul, Sazan, et al.
Publicado: (2011)

Prognostic Value of Circulating sST2 for the Prediction of Mortality in Patients With Cardiac Light-Chain Amyloidosis
por: Zhang, Yang, et al.
Publicado: (2021)

Prognostic value of interleukin-33, sST2, myeloperoxidase, and matrix metalloproteinase-9 in acute aortic dissection
por: Jia, Yu, et al.
Publicado: (2023)

Biomarkers of IL-33 and sST2 and Lack of Association with Carvedilol Therapy in Heart Failure
por: Firouzabadi, Negar, et al.
Publicado: (2020)

STADE‐HF (sST2 As a help for management of HF): a pilot study
por: Huet, Fabien, et al.
Publicado: (2020)

Diagnostic Value of sST2 in Cardiovascular Diseases: A Systematic Review and Meta-Analysis
por: Zhang, Tianyi, et al.
Publicado: (2021)

The Clinical Significance of Serum IL-33 and sST2 Alterations in the Post-Stroke Depression
por: Xu, Meirong, et al.
Publicado: (2021)

Assessment of sST2 Behaviors to Evaluate Severity/Clinical Impact of Acute Pulmonary Embolism
por: Petramala, Luigi, et al.
Publicado: (2023)

The obesity-induced adipokine sST2 exacerbates adipose T(reg) and ILC2 depletion and promotes insulin resistance
por: Zhao, Xu-Yun, et al.
Publicado: (2020)

Associations of falls and severe falls with blood pressure and frailty among Chinese community-dwelling oldest olds: The Chinese Longitudinal Health and Longevity Study
por: Song, Yujian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3pp0bkpg8imd4fu2neeerjmsba